Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Culture and Process Change as a Priority for Patient Engagement in Medicines Development.
Boutin M, Dewulf L, Hoos A, Geissler J, Todaro V, Schneider RF, Garzya V, Garvey A, Robinson P, Saffer T, Krug S, Sargeant I. Boutin M, et al. Among authors: sargeant i. Ther Innov Regul Sci. 2017 Jan;51(1):29-38. doi: 10.1177/2168479016659104. Epub 2016 Aug 20. Ther Innov Regul Sci. 2017. PMID: 28232876 Free PMC article.
Co-creation of practical "how-to guides" for patient engagement in key phases of medicines development-from theory to implementation.
Feldman D, Kruger P, Delbecque L, Duenas A, Bernard-Poenaru O, Wollenschneider S, Hicks N, Reed JA, Sargeant I, Pakarinen C, Hamoir AM; Patient Focused Medicines Development Working Groups 1; Patient Focused Medicines Development Working Groups 2A; Patient Focused Medicines Development Working Groups 2B. Feldman D, et al. Among authors: sargeant i. Res Involv Engagem. 2021 Aug 23;7(1):57. doi: 10.1186/s40900-021-00294-x. Res Involv Engagem. 2021. PMID: 34425911 Free PMC article.
US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials.
Regnante JM, Richie NA, Fashoyin-Aje L, Vichnin M, Ford M, Roy UB, Turner K, Hall LL, Gonzalez E, Esnaola N, Clark LT, Adams HC 3rd, Alese OB, Gogineni K, McNeill L, Petereit D, Sargeant I, Dang J, Obasaju C, Highsmith Q, Lee SC, Hoover SC, Williams EL, Chen MS Jr. Regnante JM, et al. Among authors: sargeant i. J Oncol Pract. 2019 Apr;15(4):e289-e299. doi: 10.1200/JOP.18.00638. Epub 2019 Mar 4. J Oncol Pract. 2019. PMID: 30830833
Operational strategies in US cancer centers of excellence that support the successful accrual of racial and ethnic minorities in clinical trials.
Regnante JM, Richie N, Fashoyin-Aje L, Hall LL, Highsmith Q, Louis J, Turner K, Hoover S, Lee SC, González E, Williams E, Adams H 3rd, Obasaju C, Sargeant I, Spinner J, Reddick C, Gandee M, Geday M, Dang J, Watson R, Chen MS Jr. Regnante JM, et al. Among authors: sargeant i. Contemp Clin Trials Commun. 2020 Jan 22;17:100532. doi: 10.1016/j.conctc.2020.100532. eCollection 2020 Mar. Contemp Clin Trials Commun. 2020. PMID: 32055746 Free PMC article.
55 results